Literature DB >> 22674800

Structural and functional characterization of the interaction of the photosensitizing probe methylene blue with Torpedo californica acetylcholinesterase.

Aviv Paz1, Esther Roth, Yacov Ashani, Yechun Xu, Valery L Shnyrov, Joel L Sussman, Israel Silman, Lev Weiner.   

Abstract

The photosensitizer, methylene blue (MB), generates singlet oxygen that irreversibly inhibits Torpedo californica acetylcholinesterase (TcAChE). In the dark, it inhibits reversibly. Binding is accompanied by a bathochromic absorption shift, used to demonstrate displacement by other acetylcholinesterase inhibitors interacting with the catalytic "anionic" subsite (CAS), the peripheral "anionic" subsite (PAS), or bridging them. MB is a noncompetitive inhibitor of TcAChE, competing with reversible inhibitors directed at both "anionic" subsites, but a single site is involved in inhibition. MB also quenches TcAChE's intrinsic fluorescence. It binds to TcAChE covalently inhibited by a small organophosphate (OP), but not an OP containing a bulky pyrene. Differential scanning calorimetry shows an ~8° increase in the denaturation temperature of the MB/TcAChE complex relative to native TcAChE, and a less than twofold increase in cooperativity of the transition. The crystal structure reveals a single MB stacked against Trp279 in the PAS, oriented down the gorge toward the CAS; it is plausible that irreversible inhibition is associated with photooxidation of this residue and others within the active-site gorge. The kinetic and spectroscopic data showing that inhibitors binding at the CAS can impede binding of MB are reconciled by docking studies showing that the conformation adopted by Phe330, midway down the gorge, in the MB/TcAChE crystal structure, precludes simultaneous binding of a second MB at the CAS. Conversely, binding of ligands at the CAS dislodges MB from its preferred locus at the PAS. The data presented demonstrate that TcAChE is a valuable model for understanding the molecular basis of local photooxidative damage.
Copyright © 2012 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674800      PMCID: PMC3537235          DOI: 10.1002/pro.2101

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  56 in total

1.  Targeted cross-linking of a molten globule form of acetylcholinesterase by the virucidal agent hypericin.

Authors:  L Weiner; E Roth; Y Mazur; I Silman
Journal:  Biochemistry       Date:  1999-08-31       Impact factor: 3.162

2.  In vitro photodynamic activity of a series of methylene blue analogues.

Authors:  Kirste J Mellish; Russell D Cox; David I Vernon; John Griffiths; Stanley B Brown
Journal:  Photochem Photobiol       Date:  2002-04       Impact factor: 3.421

3.  Spectral evidence for the presence of tryptophan in the binding site of acetylcholinesterase.

Authors:  Meir Shinitzky; Yadin Dudai; Israel Silman
Journal:  FEBS Lett       Date:  1973-02-15       Impact factor: 4.124

4.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site.

Authors:  Yves Bourne; Palmer Taylor; Zoran Radić; Pascale Marchot
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

5.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

6.  Specific chemical and structural damage to proteins produced by synchrotron radiation.

Authors:  M Weik; R B Ravelli; G Kryger; S McSweeney; M L Raves; M Harel; P Gros; I Silman; J Kroon; J L Sussman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 7.  Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules.

Authors:  Pavol Miskovsky
Journal:  Curr Drug Targets       Date:  2002-02       Impact factor: 3.465

8.  Chemical modification of Torpedo acetylcholinesterase by disulfides: appearance of a "molten globule" state.

Authors:  E A Dolginova; E Roth; I Silman; L M Weiner
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

9.  Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase.

Authors:  Clifford E Felder; Michal Harel; Israel Silman; Joel L Sussman
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

10.  A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy.

Authors:  G Lavie; C Kaplinsky; A Toren; I Aizman; D Meruelo; Y Mazur; M Mandel
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more
  5 in total

Review 1.  Tripping up Trp: Modification of protein tryptophan residues by reactive oxygen species, modes of detection, and biological consequences.

Authors:  Marilyn Ehrenshaft; Leesa J Deterding; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2015-09-21       Impact factor: 7.376

2.  Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility.

Authors:  Jonah Cheung; Ebony N Gary; Kazuro Shiomi; Terrone L Rosenberry
Journal:  ACS Med Chem Lett       Date:  2013-09-23       Impact factor: 4.345

3.  Targeted oxidation of Torpedo californica acetylcholinesterase by singlet oxygen: identification of N-formylkynurenine tryptophan derivatives within the active-site gorge of its complex with the photosensitizer methylene blue.

Authors:  Mathilde M Triquigneaux; Marilyn Ehrenshaft; Esther Roth; Israel Silman; Yakov Ashani; Ronald P Mason; Lev Weiner; Leesa J Deterding
Journal:  Biochem J       Date:  2012-11-15       Impact factor: 3.857

4.  The impact of crystallization conditions on structure-based drug design: A case study on the methylene blue/acetylcholinesterase complex.

Authors:  Orly Dym; Wanling Song; Clifford Felder; Esther Roth; Valery Shnyrov; Yacov Ashani; Yechun Xu; Robbie P Joosten; Lev Weiner; Joel L Sussman; Israel Silman
Journal:  Protein Sci       Date:  2016-03-28       Impact factor: 6.725

Review 5.  Photo-Oxidation of Therapeutic Protein Formulations: From Radical Formation to Analytical Techniques.

Authors:  Elena Hipper; Michaela Blech; Dariush Hinderberger; Patrick Garidel; Wolfgang Kaiser
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.